Significantly increased ALT levels were observed in patients with NASH and steatosis (NASH vs. normal: p = 0.018; steatosis vs. normal: p = 0.019) (Fig. 3A). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.